Physician profile
Ryan Wicks
NPI 1477874394
$1,278.04
in general payments reported to CMS, 2019-2025
11 companies · $47.00 in 2025
The $47.00 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $166 · 2020: $283 · 2021: $138 · 2022: $224 · 2023: $271 · 2024: $150 · 2025: $47.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $468.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $468.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $584.34 | 2019-2022 | |
| Abbvie INC. | $216.19 | 2023-2025 | Strattice Reconstructive Tissue Matrix Bps |
| Ethicon US, LLC | $205.14 | 2019-2023 | Enseal, Enseal X1 |
| Stryker Corporation | $56.67 | 2023 | Spy-Phi System |
| Davol INC. | $54.60 | 2021-2023 | |
| Medtronic, INC. | $50.34 | 2022-2024 | Interstim |
| Acell, INC. | $39.29 | 2019 | |
| Depuy Synthes Sales INC. | $21.72 | 2022 | |
| Aroa Biosurgery Incorporated | $20.94 | 2024 | |
| Hologic Sales and Service, LLC | $14.41 | 2023 | Coolseal Generator |
| Boston Scientific Corporation | $14.40 | 2025 | Spyglass Discover |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Wicks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.